IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces that it has entered into an agreement with Varian with the goal of validating the Dolphin transmission detector for online monitoring of patient treatment. With the health, security and safety of patients in…
As the world’s largest cardiology congress gets underway in Munich, it’s worth looking back to previous ESC sessions to see how scientific debates have evolved. At ESC 2016, held in Rome, REM-HF investigators presented data suggesting remote monitoring in implantable cardiac devices offered no added clinical benefit. Two years on, there are new reasons to re-examine that conclusion, with a…
Rutgers University–New Brunswick engineers have created a smart wristband with a wireless connection to smartphones that will enable a new wave of personal health and environmental monitoring devices. Their technology could be added to watches and other wearable devices that monitor heart rates and physical activity.
The development of new procedures to monitor cancer treatments is gathering momentum. One such innovation is liquid biopsy. This new lab technique allows non-invasive identification, characterisation and monitoring of circulating tumour DNA. Thus, liquid biopsy can potentially revolutionise oncological diagnostics – and put a spoke in the wheel of radiology. High time to act, says Professor Dr…
One of the biggest challenges in treating prostate cancer is distinguishing men who have aggressive and potentially lethal disease from men whose cancer is slow-growing and unlikely to metastasize. For years, prostate-specific antigen (PSA) level, cancer grade and tumor stage have been used to sort prostate cancer patients into risk groups established by the National Comprehensive Cancer Network.…
The Olympic Games are starting to prove themselves not just as a showcase for the world's elite athletes, but for leading-edge health IT initiatives. The International Olympic Committee and GE Healthcare announced the launch of a new analytics tool meant to enable personalized care at the 2018 Olympic Winter Games in South Korea, as well as at the 2020 Summer Games in Tokyo. GE Healthcare…
Engineers at the University of Connecticut (UConn) have created a biodegradable pressure sensor that could help doctors monitor chronic lung disease, swelling of the brain, and other medical conditions before dissolving harmlessly in a patient’s body. The UConn research is featured in the current online issue of the Proceedings of the National Academy of Sciences. The small, flexible sensor is…
No visit to the doctor’s office is complete without a blood-pressure cuff squeezing your arm and a cold stethoscope placed on your chest. But what if your vital signs could be gathered, without contact, as you sit in the waiting room or the comfort of your own home? Cornell University engineers have demonstrated a method for gathering blood pressure, heart rate and breath rate using a cheap and…
Bio-Rad Laboratories announces the launch of the "QXDx BCR-ABL %IS" Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with chronic myeloid leukemia (CML) to therapy.
30 years ago, monitoring in most intensive care environments was via an ECG display with a numeric value for heart rate combined with intermittent manual measurements of blood pressure. Advances in technology have greatly increased monitoring parameters. Eight, for example, are included in the current minimum standards for monitoring under anaesthesia but more than ten further sensors are…
A preliminary human study was conducted to validate an advanced wearable sensor which has been developed by the start-up company BioBeat Technologies Ltd, comparing it to the common manometry method. The 2015 guidelines of the European Society of Hypertension on The requirements of the International Protocol (revision 2010) were used to define the difference between the commonly used device and…
Just two decades ago, even though promising, point-of-care testing (POCT) was only used in hospitals and surgeries by a small number of specialists. Today POCT is in use throughout healthcare.
Central alarm management of the Xenios console via the Philipps IntelliVue MX800® patient monitoring system. Achieving the goal in an easy and efficient manner by a combination of safety and innovation. The Barmherzige Brüder hospital in Regensburg and Xenios combine both in the clinical practice.
Which CRT patients can be ‘downgraded’ from a CRT-D device with defibrillator function to a CRT-P with just a pacemaker function? This, with two further current CRT issues – chronotropic incompetence and telemonitoring of CRT patients – featured prominently at the Europace-Cardiostim Congress in Vienna.
A pioneering study has certified that wearable technology produced better results in monitoring cardiac patients and improving their quality of life compared to conventional systems.
Biotronik’s Home Monitoring is an award-winning remote cardiac monitoring system that automatically collects data from a patient’s cardiac device, enabling the physician to review cardiac function independently of in-office visits.
Professionals in the field of children’s cardiology will hold their world congress in FCB’s Camp Nou, Barcelona, Spain from the 16th to the 21st of July 2017. As part of the congress and for the first time, a special symposium will unite leading experts in the field of sports cardiology to discuss the heart health of the sports stars of the future.
The EASY PULSE® is an unbelievably small and light mechanical chest compression device. Performing manual chest compressions well for an extended period of time is almost impossible. Not only is it physically demanding, but other actions, such as vital signs monitoring, are also required simultaneously. SCHILLER’s EASY PULSE® is the solution for more efficient resuscitation: this portable,…
The population in Germany is more physically active than the European average. Regarding smoking, the data for Germany are quite close to the European average. However, the country does not do so well in other areas of health-related behaviour: Germany has the third lowest level of fruit consumption and the proportion of heavy episodic drinkers is above average.
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ program for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years. Therefore, key congress topics included the Zika virus, the effects of global warming and the unusually high number of hospital-acquired…
Space missions are famous for driving innovation, from Mylar blankets to microchips. So when French scientists learned one of their compatriots would be aboard the Soyuz MS-03 spacecraft to reach the International Space Station (ISS), they gathered cutting edge technologies for him to carry into orbit.
RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ monitor defibrillator at Arab Health 2017. Visitors to Stand Z1A59 will be able to see this innovative solution – which offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package – ahead of its official launch later in the year.
Remote Diagnostic Technologies Ltd (RDT) previewed its Tempus ALS™ monitor defibrillator at MEDICA 2016, ahead of its official launch in early 2017. Tempus ALS offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package.
Not having to visit hospital daily, or stay there too long, can improve the lives of patients tremendously. The Vic Hospital Consortium, in Catalonia, Spain, has begun to use a new remote monitoring system that enables it to monitor patients wherever they are. European Hospital spoke with Enrique de la Vega, digital product manager at Catalonia’s technology centre Eurecat, the organisation…
An innovative cardiac monitoring system that delivers continuous resynchronisation to patients, has shown a 35% risk reduction of hospitalisation for heart failure (HF) patients. The finding comes from the RESPOND-CRT (cardiac resynchronisation therapy) clinical trial, which was designed to investigate the clinical efficacy and safety of device-based optimisation using the SonR cardiac…